Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.

Antimicrobial agents and chemotherapy - 1 Jun 2014

Mingorance Lidia, Friesland Martina, Coto-Llerena Mairene, Pérez-del-Pulgar Sofía, Boix Loreto, López-Oliva Juan Manuel, Bruix Jordi, Forns Xavier, Gastaminza Pablo

Abstract excerpt

Hepatitis C virus (HCV) infection is a major biomedical problem worldwide as it causes severe liver disease in millions of humans around the world. Despite the recent approval of specific drugs targeting HCV replication to be used in combination with alpha interferon (IFN-α) and ribavirin, there...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Assay
Share to Cell Culture Techniques
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Interferon-alpha

Share to Ribavirin

Share to Small Molecule Libraries

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 24709263
DOI: 10.1128/AAC.02619-14
PMCID: PMC4068423

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24709263-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.PMID 24709263Read ↗

Identification of hepatitis C virus NS5A inhibitors.Semantic proximity Read ↗

Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection.Semantic proximity Read ↗

Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection.Semantic proximity Read ↗

1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitors.Semantic proximity Read ↗

Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.Semantic proximity Read ↗

Chemical genetics-based development of small molecules targeting hepatitis C virus.Semantic proximity Read ↗

A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound.Semantic proximity Read ↗

Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions.Semantic proximity Read ↗

Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.Semantic proximity Read ↗

2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action.Semantic proximity Read ↗

Resistance studies of a dithiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems.Semantic proximity Read ↗

Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.